Â
Latest Transdermal Drug Delivery Systems Companies Update
Jan 20243M Healthcare (US) Received FDA approval for their TheraPatch Lidocaine pain relief patch, expanding their portfolio and offering a convenient option for pain management.Partnered with a biotechnology company to develop a smart transdermal patch for diabetes management, utilizing real-time glucose monitoring and insulin delivery.
Pfizer Launched their Nexcare® Nicotine Patch with new features like improved adhesion and discreet design, strengthening their position in the smoking cessation market.Invested in research on using TDDS for delivering complex biologics and targeted cancer therapies.
Perrigo Company Acquired a smaller company specializing in transdermal fentanyl patches, broadening their product offerings and entering the pain management segment.Focused on developing cost-effective transdermal medications for essential drugs, aiming to improve access in underserved markets.
Hovione (Portugal) Expanded their manufacturing capacity for TDDS products to meet the growing market demand and cater to the needs of pharmaceutical companies worldwide.Collaborated with universities to develop novel transdermal technologies for improved drug delivery and patient comfort.
World Health Organization (WHO) Advocated for wider adoption of TDDS in low- and middle-income countries for delivering essential medications like hormonal contraceptives and antimalarials.Provided technical assistance and training programs to healthcare professionals in these regions to promote effective use of TDDS technologies.
List of Transdermal Drug Delivery Systems Key Companies in The Market
- Mylan NV.
- Hisamitsu Pharmaceutical Co., Inc.
- Novartis International AG
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline PLC
- Johnson & Johnson Services, Inc.
- Endo Pharmaceuticals Inc.
- UCB SA.
- Pfizer Inc.
- Allergan plc
- Actelion Pharmaceuticals Ltd
- Noven Pharmaceuticals
